Donglin Yan
5PUBLICATIONS
13CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Feb 27, 2026
A Phase 1 Dose Escalation of Lapatinib and Paclitaxel in Recurrent Ovarian Cancer.Connie D Cao, Joseph Robert McCorkle, Donglin Yan
|Jan 15, 2026
Assessing the Value of Sequential Next-Generation Sequencing and Multiple Molecular Tumor Board Reviews for Patients With Solid-Tumor Malignancies.Allison L Swiecki-Sikora, Lydia Williams, Ning Li
|Sep 30, 2024
Phase I clinical trial designs in oncology: A systematic literature review from 2020 to 2022.Ning Li, Xitong Zhou, Donglin Yan
|Sep 11, 2024
Clinical Utility of Molecular Tumor Board Review for Identification of Possible Germline Pathogenic Variants on Tumor Next-Generation Sequencing Reports.Taylor A Rives, James Collard, Ning Li
|May 13, 2023
A Phase I Dose Escalation and Expansion Study of Epidiolex (Cannabidiol) in Patients with Biochemically Recurrent Prostate Cancer.Zin W Myint, William H St Clair, Stephen E Strup
Pageof 1
Frequent Collaborators
3 joint publications
Rachel W Miller
2 joint publications
Ning Li
2 joint publications
Derek B Allison
2 joint publications
Frederick R Ueland
2 joint publications
Jill M Kolesar
1 joint publications
Zin W Myint
1 joint publications
Stephen E Strup
1 joint publications
Jill M Kolesar
1 joint publications
Taylor A Rives
1 joint publications
James Collard
